The Steven Coutre Review of the 66th Annual American Society of Hematology Meeting

Early Bird Rates:
Physicians/Nurses/Allied Health Professionals: $199
Industry: $549

Regular Rates as of 12/1/24:
Physicians/Nurses: $249
Allied Health Professionals: $249

Industry: $649 - CLOSED, please click here to be added to the waitlist

1. Implement the use of new chemotherapeutics and biologics in subpopulations of acute myeloid leukemia patients based on patient clinical and genetic profiles
2. Review new drug approvals and practical considerations for their safe and optimal use
3. Evaluate optimal sequencing and combinations of novel agents for CLL and lymphomas
4. Asses the role of new therapies in classical (non-malignant) hematology indications
5. Discuss available therapeutic options for patients with low- or high-risk myelodysplastic syndromes

In support of improving patient care, Stanford Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. 

Credit Designation 
American Medical Association (AMA) 
Stanford Medicine designates this Live Activity for a maximum of 7.25 AMA PRA Category 1 Credits^TM.  Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

American Board of Internal Medicine MOC Credit 
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 7.25 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MOC Participation Threshold

Learner completes answers to a quiz, percent of correct answers required will be set by provider.

Cancellation Policy
Live Activities: Cancellations received in writing no less than 20 days before the course will be refunded. No refunds will be made on cancellations received after that date. Self-paced Activities: No refunds will be made on cancellation requests after a learner accesses any part of the course content. Any cancellations refunded will less a 20% administrative fee. Please send cancellation requests to [email protected].

Stanford University School of Medicine reserves the right to cancel or postpone this program if necessary; in the event of cancellation, course fees will be fully refunded. We are not responsible for other costs, such as non-refundable airline tickets or hotel penalties.

Accessibility Statement
 Stanford University School of Medicine is committed to ensuring that its programs, services, goods and facilities are accessible to individuals with disabilities as specified under Section 504 of the Rehabilitation Act of 1973 and the Americans with Disabilities Amendments Act of 2008.  If you have needs that require special accommodations, including dietary concerns, please contact the CME.

Cultural and Linguistic Competency
The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area for the purpose of complying with California Assembly Bill 1195. Moreover, the Stanford University School of Medicine Multicultural Health Portal contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.  You are encouraged to visit the Multicultural Health Portal: https://laneguides.stanford.edu/multicultural-health

For activity related questions, please contact
      Amanda Harrison
      Event Planner
      [email protected]

For CME general questions, please contact 
     Email: [email protected]

The Ritz Carlton - Half Moon Bay 
 1 Miramontes Point Rd,
Half Moon Bay, CA 94019

The room block is fully booked, and no additional rooms will be added.

Mitigation of Relevant Financial Relationships

Stanford Medicine adheres to the Standards for Integrity and Independence in Accredited Continuing Education.

Disclosure of faculty and their commercial relationships will be made prior to the activity.

Member Information

Role in activity

Nature of Relationship(s) / Name of Ineligible Company(s)

William Shomali, MD
Clinical Assistant Professor, Hematology
Stanford University

Co-Course Director, Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Incyte|Grant or research support-Incyte|Grant or research support-Blueprint Medicines

Tian Zhang, MD
Assistant Professor of Medicine, Hematology
Stanford University

Co-Course Director, Faculty

Nothing to disclose

Ranjana Advani, MD
Saul A. Rosenberg, Professor of Lymphoma, Oncology
SHC - Cancer Center

Faculty

Grant or research support-BeiGene|Grant or research support-Millennium Pharmaceuticals, Inc.|Grant or research support-Genentech, Inc.|Grant or research support-Genmab|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-BeiGene|Grant or research support-Regeneron|Grant or research support-Seattle Genetics|Grant or research support-Seattle Genetics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-ADC Therapuetics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Roche|Grant or research support-Roche|Grant or research support-Merck and Company, Inc.|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Merck and Company, Inc. (Relationship has ended)|Grant or research support-Daiichi Sankyo|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Autolus Limited

Rondeep Singh Brar, MD
Clinical Associate Professor
Stanford Hospital & Clinics

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Apellis Pharmaceuticals|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Alexion Pharmaceuticals|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Novartis AG

Kenneth Chen, MD, PhD
Stanford

Faculty

Nothing to disclose

May Chien, MD
Clinical Assistant Professor of Medicine, Hematology
Clinical Assistant Professor of Pediatrics Hematology/Oncology
Division of Hematology, Oncology, Stem Cell Transplantation & Regenerative Medicine
Stanford University School of Medicine

Faculty

Nothing to disclose

Nicole Dalal, MD
Fellow
Stanford University

Faculty

Nothing to disclose

Robert Diep, MD
Clinical Assistant Professor, Hematology
SHC - Cancer Center

Faculty

Membership on Advisory Committees or Review Panels, Board Membership, etc.-Sobi (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Shield Therapeutics (Relationship has ended)|Grant or research support-Veralox Therapeutics

Bita Fakhri, MD
Assistant Professor of Medicine, Hematology
Stanford University

Faculty

Advisor-Abbvie|Advisor-AstraZeneca|Advisor-Beigene|Advisor-Genentech, Inc.|Advisor-Genmab|Advisor-Bristol-Myers Squibb|Advisor-Eli Lilly and Company|Advisor-TG Therapeutics|Advisor-Pharmacyclics|Grant or research support-Angiocrine|Grant or research support-Abbvie|Grant or research support-Bristol-Myers Squibb|Grant or research support-Eli Lilly and Company|Grant or research support-Genmab|Grant or research support-Genentech, Inc.

Jason Gotlib, MD

Faculty

Grant or research support-Incyte|Grant or research support-Blueprint Medicines|Grant or research support-Cogent Biosciences|Grant or research support-Protagonist Therapeutics|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Incyte|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Blueprint Medicines|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Cogent Biosciences

Peter Greenberg, MD
Professor of Medicine
Stanford University Cancer Center
Us

Faculty

Grant or research support-Gilead|Grant or research support-Aprea|Paid consultant-Hemavant

David Iberri, MD
Assistant Professor of Medicine (Hematology)
SHC - Cancer Center

Faculty

Nothing to disclose

Vanessa E Kennedy, MD
Assistant Professor of Medicine (Blood and Marrow Transplantation)
Stanford University School of Medicine

Faculty

Consulting Fee-Astellas

Lawrence Leung, MD
Maureen Lyles D'Ambrogio Professor in the School of Medicine, Hematology
Stanford University

Faculty

Nothing to disclose

Michaela Liedtke, MD
Associate Professor of Medicine (Hematology)
Stanford University School of Medicine

Faculty

Advisor-Abbvie (Relationship has ended)|Advisor-Alexion (Relationship has ended)|Advisor-AstraZeneca (Relationship has ended)|Advisor-Jazz Pharmaceuticals (Relationship has ended)|Advisor-Nexcella|Advisor-Sanofi-Aventis (Relationship has ended)

James Mathew Malone, MD
Clinical Associate Professor of Medicine
Stanford University

Faculty

Nothing to disclose

Gabriel Mannis, MD
Associate Professor of Medicine (Hematology)
Stanford University School of Medicine

Faculty

Consulting Fee-Abbvie|Consulting Fee-Agios (Relationship has ended)|Consulting Fee-Servier (Relationship has ended)|Consulting Fee-Stemline|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Abbvie|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Agios (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Astellas (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-BMS-Celgene (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Genentech|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Immunogen (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Orbital (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Rigel (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Servier (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Stemline (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Taiho (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Wugen (Relationship has ended)|Grant or research support-Aptose|Grant or research support-Blossom Hill|Grant or research support-Glycomimetics (Relationship has ended)|Grant or research support-Gilead (Relationship has ended)|Grant or research support-Jazz (Relationship has ended)|Grant or research support-Astex-Taiho |Grant or research support-Syndax |Grant or research support-ImmuneOnc (Relationship has ended)|Grant or research support-BMS-Celgene (Relationship has ended)

Beth A. Martin, MD
Clinical Associate Professor, Medicine - Hematology
Stanford University School of Medicine

Faculty

Nothing to disclose

Alfonso Molina Jr., MD, MPH
Resident
Department of Medicine

Faculty

Nothing to disclose

Ann Mullally, MD
MD
Stanford University

Faculty

Consulting Fee-Incyte (Relationship has ended)|Membership on Advisory Committees or Review Panels, Board Membership, etc.-Protagonist (Relationship has ended)|Consulting Fee-Cellarity (Relationship has ended)|Grant or research support-Morphic (Relationship has ended)|Grant or research support-Relay (Relationship has ended)|Consulting Fee-Nuvalent (Relationship has ended)|Consulting Fee-PharmaEssentia (Relationship has ended)

Jean Soonmyong Oak, MD, PhD
faculty
Stanford University

Faculty

Nothing to disclose

Ghazal Salmasi, MD
Clinical Associate Professor, Medicine, Hematology
Stanford University

Faculty

Nothing to disclose

Gabriel Salzman, MD, PhD
Stanford

Faculty

Nothing to disclose

Oscar Silva, MD
Clinical Assistant Professor, Pathology
Stanford University

Faculty

Nothing to disclose

Hrishikesh K Srinagesh, MD
Fellow
Stanford

Faculty

Honoraria-Takeda Pharmaceuticals, Inc. (Relationship has ended)|Stocks or stock options, excluding diversified mutual funds-Verve therapeutics

Seena Tabibi, MD
Pathology

Faculty

Nothing to disclose

James Zehnder, MD
Professor of Medicine, Pathology, Hematology
Stanford University

Faculty

Nothing to disclose

Saturday, February 8, 2025

This CME Activity is supported in part by educational grants from AstraZeneca & Lilly.